| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/13697137.2012.666456 |
| P8608 | Fatcat ID | release_adzixrgpkfawjmac5zzrqvly7a |
| P698 | PubMed publication ID | 22612610 |
| P2093 | author name string | R J Santen | |
| A Gompel | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol | Q30308284 | ||
| Postmenopausal hormone therapy: an Endocrine Society scientific statement. | Q30451123 | ||
| Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data | Q34018653 | ||
| Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use | Q34131826 | ||
| Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study | Q34132812 | ||
| Mammographic density and breast cancer risk: current understanding and future prospects | Q34235753 | ||
| Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study | Q34334908 | ||
| Changes in Invasive Breast Cancer and Ductal Carcinoma In Situ Rates in Relation to the Decline in Hormone Therapy Use | Q34488648 | ||
| Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. | Q34512916 | ||
| Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort | Q34552706 | ||
| Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study | Q34576753 | ||
| Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status | Q34581334 | ||
| The decrease in breast-cancer incidence in 2003 in the United States | Q34620356 | ||
| Risk factor modification and projections of absolute breast cancer risk | Q35090578 | ||
| Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time | Q35571438 | ||
| From in vivo gene targeting of oestrogen receptors to optimization of their modulation in menopause. | Q35657905 | ||
| Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk | Q35797100 | ||
| Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women | Q35906269 | ||
| Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women | Q35994063 | ||
| Hip fracture in postmenopausal women after cessation of hormone therapy: results from a prospective study in a large health management organization | Q36436644 | ||
| Hormone therapy and breast cancer risk | Q36946798 | ||
| Breast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women's health initiative clinical trials | Q36971892 | ||
| Insulin resistance, obesity and breast cancer risk | Q37165985 | ||
| Physical activity and breast cancer risk: impact of timing, type and dose of activity and population subgroup effects. | Q37166937 | ||
| Declining breast cancer incidence and decreased HRT use. | Q37250420 | ||
| The role of physical activity in breast cancer etiology. | Q37779950 | ||
| Is the decrease in breast cancer incidence related to a decrease in postmenopausal hormone therapy? | Q37788770 | ||
| Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study | Q43043857 | ||
| Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study | Q43260471 | ||
| Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition | Q43520576 | ||
| Breast cancer incidence rates in U.S. women are no longer declining | Q44617798 | ||
| A decline in breast-cancer incidence. | Q45145851 | ||
| Breast cancer risk in postmenopausal women using estradiol-progestogen therapy | Q46185602 | ||
| Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004. | Q51111297 | ||
| Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations | Q57414978 | ||
| Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case-Control Study | Q59288218 | ||
| P433 | issue | 3 | |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 241-249 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Climacteric | Q5133381 |
| P1476 | title | Hormone therapy and breast cancer risk 10 years after the WHI. | |
| P478 | volume | 15 |
| Q39165724 | A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms |
| Q33789138 | Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial |
| Q37210143 | Anti-Atherosclerotic Effects of a Phytoestrogen-Rich Herbal Preparation in Postmenopausal Women. |
| Q55096110 | Aromatherapy for Sexual Problems in Menopausal Women: A Systematic Review and Meta-analysis. |
| Q38410558 | Association between the NBS1 Glu185Gln polymorphism and breast cancer risk: a meta-analysis |
| Q40210721 | Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. |
| Q26773565 | Effects of red clover on hot flash and circulating hormone concentrations in menopausal women: a systematic review and meta-analysis |
| Q22064616 | Genome-wide association studies and the clinic: a focus on breast cancer |
| Q28294446 | HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT |
| Q38011779 | Have we come full circle - or moved forward? The Women's Health Initiative 10 years on. |
| Q34963585 | Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis |
| Q38975101 | Hormone-replacement therapy: current thinking |
| Q38350761 | Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part I. |
| Q38350780 | Hormones, herbal preparations and nutriceuticals for a better life after the menopause: part II. |
| Q41414568 | How can information on the risk of breast cancer and hormone therapy be better understood? |
| Q39175806 | Long-Term Hormone Replacement Therapy Is Associated with Low Coronary Artery Calcium Levels in a Cohort of Older Women: The Age, Gene/Environment Susceptibility-Reykjavik Study |
| Q37705069 | Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation |
| Q38127837 | Oncology in midlife and beyond. |
| Q36809567 | Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma |
| Q37723290 | Perceptions of Postmenopausal Symptoms and Treatment Options among Middle-Aged Korean Women. |
| Q38399459 | Primary prevention of cardiovascular disease with hormone replacement therapy |
| Q34498154 | Red clover for treatment of hot flashes and menopausal symptoms: A systematic review and meta-analysis |
| Q38600186 | The application of soy isoflavones for subjective symptoms and objective signs of vaginal atrophy in menopause: A systematic review of randomised controlled trials |
| Q57131263 | The benefits and harms of breast cancer screening: an independent review |
| Q30374057 | Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30 |
| Q38106748 | Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health. |
Search more.